Lyrica launches with professional education push
Pfizer has launched Lyrica (pregabalin), its drug for neuropathic pain and epilepsy and the anticipated successor to Neurontin.
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.